293 related articles for article (PubMed ID: 25337833)
1. Association between cytochrome CYP17A1, CYP3A4, and CYP3A43 polymorphisms and prostate cancer risk and aggressiveness in a Korean study population.
Han JH; Lee YS; Kim HJ; Lee SY; Myung SC
Asian J Androl; 2015; 17(2):285-91. PubMed ID: 25337833
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive evaluation of the association between prostate cancer and genotypes/haplotypes in CYP17A1, CYP3A4, and SRD5A2.
Loukola A; Chadha M; Penn SG; Rank D; Conti DV; Thompson D; Cicek M; Love B; Bivolarevic V; Yang Q; Jiang Y; Hanzel DK; Dains K; Paris PL; Casey G; Witte JS
Eur J Hum Genet; 2004 Apr; 12(4):321-32. PubMed ID: 14560315
[TBL] [Abstract][Full Text] [Related]
3. CYP3A4, CYP3A5, and CYP3A43 genotypes and haplotypes in the etiology and severity of prostate cancer.
Zeigler-Johnson C; Friebel T; Walker AH; Wang Y; Spangler E; Panossian S; Patacsil M; Aplenc R; Wein AJ; Malkowicz SB; Rebbeck TR
Cancer Res; 2004 Nov; 64(22):8461-7. PubMed ID: 15548719
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the influence of polymorphic variants CYP1A1 2B, CYP1B1 2, CYP3A4 1B, GSTM1 0, and GSTT1 0 in prostate cancer.
Rodrigues IS; Kuasne H; Losi-Guembarovski R; Fuganti PE; Gregório EP; Kishima MO; Ito K; de Freitas Rodrigues MA; de Syllos Cólus IM
Urol Oncol; 2011; 29(6):654-63. PubMed ID: 20884258
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in CYP17 and CYP3A4 and prostate cancer in men of African descent.
Taioli E; Sears V; Watson A; Flores-Obando RE; Jackson MD; Ukoli FA; de Syllos Cólus IM; Fernandez P; McFarlane-Anderson N; Ostrander EA; Rodrigues IS; Stanford JL; Taylor JA; Tulloch-Reid M; Ragin CC
Prostate; 2013 May; 73(6):668-76. PubMed ID: 23129512
[TBL] [Abstract][Full Text] [Related]
6. Haplotype analyses of CYP17A1 genetic polymorphisms and coronary artery disease in a Uygur population.
Dai CF; Xie X; Ma YT; Yang YN; Li XM; Fu ZY; Liu F; Chen BD; Gai MT
J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):389-98. PubMed ID: 25592814
[TBL] [Abstract][Full Text] [Related]
7. Decision tree-based modeling of androgen pathway genes and prostate cancer risk.
Barnholtz-Sloan JS; Guan X; Zeigler-Johnson C; Meropol NJ; Rebbeck TR
Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1146-55. PubMed ID: 21493872
[TBL] [Abstract][Full Text] [Related]
8. The association of 5-alpha reductase type 2 (SRD5A2) gene polymorphisms with prostate cancer in a Korean population.
Choi SY; Kim HJ; Cheong HS; Myung SC
Korean J Urol; 2015 Jan; 56(1):19-30. PubMed ID: 25598933
[TBL] [Abstract][Full Text] [Related]
9. Association of CYP17A1 Genetic Polymorphisms and Susceptibility to Essential Hypertension in the Southwest Han Chinese Population.
Li Q; Gao T; Yuan Y; Wu Y; Huang Q; Xie F; Ran P; Sun L; Xiao C
Med Sci Monit; 2017 May; 23():2488-2499. PubMed ID: 28537227
[TBL] [Abstract][Full Text] [Related]
10. Genetic polymorphisms of CYP17A1, vitamin D receptor and androgen receptor in Italian heredo-familial and sporadic prostate cancers.
Risio M; Venesio T; Kolomoets E; Armaroli P; Gallo F; Balsamo A; Muto G; D'Urso L; Puppo P; Naselli A; Segnan N;
Cancer Epidemiol; 2011 Aug; 35(4):e18-24. PubMed ID: 21094112
[TBL] [Abstract][Full Text] [Related]
11. Genetic variants in the CYP24A1 gene are associated with prostate cancer risk and aggressiveness in a Korean study population.
Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Choi WS; Kim D; Kim HJ; Myung SC
Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):149-56. PubMed ID: 24492489
[TBL] [Abstract][Full Text] [Related]
12. CYP3A4 and CYP3A5 genotypes, haplotypes, and risk of prostate cancer.
Plummer SJ; Conti DV; Paris PL; Curran AP; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):928-32. PubMed ID: 14504207
[TBL] [Abstract][Full Text] [Related]
13. Haplotype-based association studies of IGFBP1 and IGFBP3 with prostate and breast cancer risk: the multiethnic cohort.
Cheng I; Penney KL; Stram DO; Le Marchand L; Giorgi E; Haiman CA; Kolonel LN; Pike M; Hirschhorn J; Henderson BE; Freedman ML
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1993-7. PubMed ID: 17035411
[TBL] [Abstract][Full Text] [Related]
14. Role of androgen metabolism genes CYP1B1, PSA/KLK3, and CYP11alpha in prostate cancer risk and aggressiveness.
Cicek MS; Liu X; Casey G; Witte JS
Cancer Epidemiol Biomarkers Prev; 2005 Sep; 14(9):2173-7. PubMed ID: 16172228
[TBL] [Abstract][Full Text] [Related]
15. CYP17A1 Polymorphisms Are Linked to the Risk of Coronary Heart Disease in a Case-Control Study.
Lu S; Zhong J; Zhang Y; Huang K; Wu M; Zhou Y; Li Q; Chen Z; Zhang S; Zhou H
J Cardiovasc Pharmacol; 2019 Aug; 74(2):98-104. PubMed ID: 31356544
[TBL] [Abstract][Full Text] [Related]
16. Profiling genetic variation along the androgen biosynthesis and metabolism pathways implicates several single nucleotide polymorphisms and their combinations as prostate cancer risk factors.
Mononen N; Seppälä EH; Duggal P; Autio V; Ikonen T; Ellonen P; Saharinen J; Saarela J; Vihinen M; Tammela TL; Kallioniemi O; Bailey-Wilson JE; Schleutker J
Cancer Res; 2006 Jan; 66(2):743-7. PubMed ID: 16424004
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations in VDR associated with prostate cancer risk and progression in a Korean population.
Oh JJ; Byun SS; Lee SE; Hong SK; Jeong CW; Kim D; Kim HJ; Myung SC
Gene; 2014 Jan; 533(1):86-93. PubMed ID: 24120391
[TBL] [Abstract][Full Text] [Related]
18. Associations Between Cytochrome P450 (CYP) Gene Single-Nucleotide Polymorphisms and Second-to-Fourth Digit Ratio in Chinese University Students.
Zhang J; Yang M; Luan P; Jia W; Liu Q; Ma Z; Dang J; Lu H; Ma Q; Wang Y; Mu C; Huo Z
Med Sci Monit; 2021 Mar; 27():e930591. PubMed ID: 33723203
[TBL] [Abstract][Full Text] [Related]
19. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
20. Prostate cancer associated with CYP17 genotype.
Wadelius M; Andersson AO; Johansson JE; Wadelius C; Rane E
Pharmacogenetics; 1999 Oct; 9(5):635-9. PubMed ID: 10591544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]